newsfilter
← Latest News
GlobeNewswire·

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

AUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ:FLNA, "Filana Therapeutics", the "Company")), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis